• Articles
  • Cases
  • News
  • Issues
  • CME / CE
  • Podcasts
  • Blog
  • Student Scan
  • Resources
SUBSCRIBE
MOST RECENT
FDA Approves New PYLARIFY TruVu Formulation for Enhanced Prostate Cancer Imaging Telix Submits Revised New Drug Application for Brain Cancer Imaging Agent TLX101-Px to FDA AI-Enhanced Mammography Improves Risk Prediction in Breast Cancer Screening AidaBreast™ Validates as Predictive Tool for Breast Cancer Radiotherapy Decisions Study Finds No Increase in Toxicity with Combined Radiation Treatments for Liver Cancer Key Milestones Achieved in ProstACT Global Phase 3 Study of TLX591-Tx Innovative Radiotheranostic Therapy Under Investigation for Aggressive Bone Cancer Supplemental MRI May Benefit Women With Dense Breasts at Higher Cancer Risk Stereotactic Radiation Therapy Outperforms Whole-Brain Radiation for Brain Metastases 2026 National Proton Conference to Highlight Key Advances and Access Initiatives

Click here for Advertiser Information.

Click here to view Submission Guidelines.

Click here to view Editorial Policies.

Click here to Download Forms.

Click here to Subscribe.

Click here to Contact Us.

Editorial Resources

  • Submission Guidelines
  • Editorial Policies
  • Forms for Authors

Journal Resources

  • Advertise
  • Subscribe
  • Address Change
  • Email Alert Manager
  • Contact

Social

© Anderson Publishing, Ltd. 2026 All rights reserved. Reproduction in whole or part without express written permission Is strictly prohibited. Designed and coded by Little Tiger.
  • Contact Us
  • Privacy Policy
  • Terms and Conditions